BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6326529)

  • 1. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of cyclic nucleotide phosphodiesterase activity.
    Vaughan M; Danello MA; Manganiello VC; Strewler GJ
    Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
    [No Abstract]   [Full Text] [Related]  

  • 3. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of cyclic nucleotide phosphodiesterases in S49 mouse lymphoma cells.
    Bourne HR; Brothers VM; Kaslow HR; Groppi V; Walker N; Steinberg F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():185-94. PubMed ID: 6326523
    [No Abstract]   [Full Text] [Related]  

  • 8. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 10. Calmodulin-dependent cyclic nucleotide phosphodiesterases in the immature rat testis.
    Purvis K; Olsen A; Hansson V
    J Biol Chem; 1981 Nov; 256(22):11434-41. PubMed ID: 6271749
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
    Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
    Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis.
    Solomon SS; Palazzolo M; King LE
    Diabetes; 1977 Oct; 26(10):967-72. PubMed ID: 198322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of rat liver cyclic 3':5'-nucleotide phosphodiesterase by cyclic GMP is dependent on enzyme concentration.
    Guan WR; Cheung WY
    Arch Biochem Biophys; 1980 Oct; 204(1):191-8. PubMed ID: 6252844
    [No Abstract]   [Full Text] [Related]  

  • 15. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
    Perez de Gracia B; Rhoads AR; West WL
    Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and properties of cyclic nucleotide phosphodiesterases.
    Beavo JA; Hansen RS; Harrison SA; Hurwitz RL; Martins TJ; Mumby MC
    Mol Cell Endocrinol; 1982; 28(3):387-410. PubMed ID: 6185373
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membraneous and cytosolic cyclic-nucleotide phosphodiesterases in beef aorta: substrate specificity, endogenous inhibition and activation [proceedings].
    Ilien B; Morel A; Stierle A; Landry Y
    Arch Int Physiol Biochim; 1978 Oct; 86(4):865-7. PubMed ID: 84582
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases.
    Wells JN; Hardman JG
    Adv Cyclic Nucleotide Res; 1977; 8():119-43. PubMed ID: 200125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.